Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
2012 · Blood · 233 citations
https://doi.org/10.1182/blood-2012-02-400937
D
Donald B. Kohn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
656
Papers
28.7K
Citations
90
h-index
327
i10-index
Donald B. Kohn is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Virus-based gene therapy research & CAR-T cell therapy research & CRISPR and Genetic Engineering. The author has an h-index of 90, co-authored 558 publications.
ORCID: 0000-0003-1840-6087Papers by this author
worksConsensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency
2018 · Journal of Allergy and Clinical Immunology · 130 citations
https://doi.org/10.1016/j.jaci.2018.08.024
Leukocyte adhesion deficiency-I: A comprehensive review of all published cases
2018 · The Journal of Allergy and Clinical Immunology In Practice · 114 citations
https://doi.org/10.1016/j.jaip.2017.12.008
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations
2017 · Journal of Clinical Immunology · 109 citations
https://doi.org/10.1007/s10875-017-0433-3
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions
2022 · Journal of Allergy and Clinical Immunology · 107 citations
https://doi.org/10.1016/j.jaci.2022.10.022
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
2024 · Nature Biotechnology · 76 citations
https://doi.org/10.1038/s41587-024-02226-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat